A new study reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer treatment. This comprehensive analysis represents a significant advancement in the understanding of these unique immune cells and their implications for patient outcomes in cancer therapy.
source https://www.sciencedaily.com/releases/2024/10/241004121653.htm
I've studied organizational failure for decades—the Church of England needs
more than a new leader
-
In a book I wrote with a colleague on organizational failures (The Apology
Impulse) the inability of many of them to confront their failures, except
to say...
11 hours ago
No comments:
Post a Comment